Authors:
Haese, A
Graefen, M
Steuber, T
Becker, C
Pettersson, K
Piironen, T
Noldus, J
Huland, H
Lilja, H
Citation: A. Haese et al., Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml, PROSTATE, 49(2), 2001, pp. 101-109
Authors:
Nurmikko, P
Pettersson, K
Piironen, T
Hugosson, J
Lilja, H
Citation: P. Nurmikko et al., Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys(145)-Lys(146), CLIN CHEM, 47(8), 2001, pp. 1415-1423
Authors:
Piironen, T
Nurmi, M
Irjala, K
Heinonen, O
Lilja, H
Lovgren, T
Pettersson, K
Citation: T. Piironen et al., Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: Implications for point-of-care testing, CLIN CHEM, 47(4), 2001, pp. 703-711
Authors:
Siivola, P
Pettersson, K
Piironen, T
Lovgren, T
Lilja, H
Bjartell, A
Citation: P. Siivola et al., Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections, UROLOGY, 56(4), 2000, pp. 682-688
Authors:
Becker, C
Piironen, T
Pettersson, K
Hugosson, J
Lilja, H
Citation: C. Becker et al., Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater, UROLOGY, 55(5), 2000, pp. 694-699
Authors:
Recker, F
Kwiatkowski, MK
Piironen, T
Pettersson, K
Huber, A
Lummen, G
Tscholl, R
Citation: F. Recker et al., Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen, UROLOGY, 55(4), 2000, pp. 481-485
Authors:
Becker, C
Piironen, T
Pettersson, K
Bjork, T
Wojno, KJ
Oesterling, JE
Lilja, H
Citation: C. Becker et al., Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (hK2) in serum, J UROL, 163(1), 2000, pp. 311-316
Authors:
Nurmikko, P
Vaisanen, V
Piironen, T
Lindgren, S
Lilja, H
Pettersson, K
Citation: P. Nurmikko et al., Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA, CLIN CHEM, 46(10), 2000, pp. 1610-1618
Authors:
Vaisanen, V
Lovgren, L
Hellman, J
Piironen, T
Lilja, H
Pettersson, K
Citation: V. Vaisanen et al., Characterization and processing of prostate specific antigen (hk3) and human glandular kallikrein (hK2) secreted by LNCaP cells, PROSTATE C, 2(2), 1999, pp. 91-97
Authors:
Stenman, UH
Paus, E
Allard, WJ
Andersson, I
Andres, C
Barnett, TR
Becker, C
Belenky, A
Bellanger, L
Pellegrino, CM
Bormer, OP
Davis, G
Dowell, B
Grauer, LS
Jette, DC
Karlsson, B
Kreutz, FT
van der Kwast, TM
Lauren, L
Leinimaa, M
Leinonen, J
Lilja, H
Linton, HJ
Nap, M
Nilsson, O
Ng, PC
Nustad, K
Peter, A
Pettersson, K
Piironen, T
Rapp, J
Rittenhouse, HG
Rye, PD
Seguin, P
Slota, J
Sokoloff, RL
Suresh, MR
Very, DL
Wang, TJ
Wigheden, I
Wolfert, RL
Yeung, KK
Zhang, WM
Zhou, Z
Hilgers, J
Citation: Uh. Stenman et al., Summary report of the TD-3 workshop: Characterization of 83 antibodies against prostate-specific antigen, TUMOR BIOL, 20, 1999, pp. 1-12
Authors:
Lilja, H
Haese, A
Bjork, T
Friedrich, MG
Piironen, T
Pettersson, K
Huland, E
Huland, H
Citation: H. Lilja et al., Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy, J UROL, 162(6), 1999, pp. 2029-2034
Authors:
Recker, F
Kwiatkowski, WK
Piironen, T
Pettersson, K
Lummen, G
Wernli, M
Wiefelsputz, J
Graber, SF
Goepel, M
Huber, A
Tscholl, R
Citation: F. Recker et al., The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma, CANCER, 83(12), 1998, pp. 2540-2547